19 Indian firms get licence to make Pfizer's oral generic

The Medicines Patent Pool (MPP) has granted licences to 19 Indian pharmaceutical firms to manufacture and commercialise the generic version of Paxlovid, Pfizer's oral antiviral Covid-19 pill.

Bharat Serums buys 26 pc stake in solar power firm AMP Energy C&I One

Bharat Serums and Vaccines on Thursday said it has acquired a 26 per cent stake in AMP Energy C&I One to support green energy requirements for its manufacturing facility at Ambernath in Maharashtra. Aimed at driving a comprehensive sustainability blu

Corbevax to cost Rs 800 in shop & Rs 145 for the govt

Corbevax, the Covid-19 vaccine used for children aged 12 to 14 years, is being sold to the government at only ₹145 per dose, Biological E said on Wednesday even as the country kick-started the vaccination

How Natural Language Processing is Transforming the Pharmaceutical Industry

Mainly, pharmaceutical companies are faced with a constant stream of new data flowing into often siloed information systems.

Hidoc Dr launches India's first KOL Factory to bridge gap between drug firms and reputed doctors

Hidoc Dr, India's most comprehensive platform for doctors' networking, has launched a one-stop solution known as Key Opinion Leaders (KOL) Factory to bridge the gap between pharmaceutical businesses and India's top doctors in the wake of the Covid-19

NTAGI to examine data from CMC Vellore's study on mixing and matching of Covid-19 vaccines

The Covid-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review data from a study conducted by Christian Medical College (CMC), Vellore on mixing and matching of Covid-19 vaccines-in a meeting to be held

Alembic Pharma gets USFDA permission for $797 mn generic BP drug

Alembic Pharmaceuticals said it received tentative approval from the US Food & Drug Administration to launch a generic form of blood pressure tablet Opsumit.Alembic Pharmaceuticals said it received tentative approval from the US Food & Drug Administr

Unique deal gives desi pharma companies share of cancer drug's $8 billion US pie

A blockbuster cancer drug in the US with annual sales of over $8 billion may just become a win-win for all stakeholders - the innovator, domestic generic companies as well as patients. This is in the wake of a 'unique' patent settlement where US majo

Flexible manufacturing to Transform the Pharma Ecosystem

The times are changing, so are the methods in which the pharmaceutical sector used to function.

Govt announces norms for strengthening of pharma industry scheme

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers on Friday released guidelines for 'Strengthening of Pharmaceutical Industry (SPI)' scheme that is seen to address rising demand in terms of support required to existing Pharma clust

© 2025 India Pharma Outlook. All Rights Reserved.